Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Acologix, Inc.
In a busy month, MD Anderson also partners with Ipsen on an unspecified cancer drug and licenses poziotinib IP to Spectrum. Using IP from UCLA, Bloom launches with focus on neuroprotective epilepsy therapies.
Mitsubishi Tanabe Pharma (MTP) has acquired for undisclosed terms the development and commercialisation rights in North America to Toray's nalfurafine (TRK-820).
Economic recovery, pharmaceutical consolidation, and a burgeoning private equity sector have encouraged a new cluster of Japan-focused specialty pharmas
- Other Names / Subsidiaries
- Big Bear Bio, Inc.